Login

Anton Pillay, CEO of Coronation Fund Managers, discusses the company's adjustment to payment processes in a "#PayIn30" initiative. 00:10:00

Share On Facebook Share On Twitter

Anton Pillay, CEO of Coronation Fund Managers,

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Midas Gold Advances Large-Scale Development Project in Idaho
00:10:00
Unlocking the Power of Giving with Daffy.Org|Adam Nash,CEO & Co-Founder, Daffy.org
00:10:00
Interactive Brokers Chairman discusses the company's Q2 earnings beat.
00:10:00
Lenity Financial: Premier Investment and Financial Planning Services | Mark Bova, Co-Founders , Lenity Financial, Inc.
00:10:00
Interview with Jonathan Sands: Director of Sands Wealth Management on Sponsoring Project Yorkshire
00:10:00
Fireweed Zinc: High-Grade Zinc-Lead-Silver Exploration in Canada's Yukon Territory
00:10:00
Virginie Morgon Unveils Eurazeo's September Initiatives | Virginie Morgon, CEO, Eurazeo.
00:10:00
Interim Report Update: Genova Property Group’s Performance and Future Outlook | Michael Moschewitz, CEO , Genova Property Group AB.
00:10:00
EQT CEO Christian Sinding on Global Markets, Investment Strategies, and Future Opportunities | Christian Sinding, CEO, EQT.
00:10:00
Embracing Diversity in Brussels: Harold Boël at Digityser's Grand Opening | Harold Boël, CEO, Sofina.
00:10:00
The International Investment Forum (IIF) offers insights on global investment trends and ideas across industries, sourced from top executives and managers worldwide.|Lindsay Dudfield Ceo of Jindalee Resources Limited
00:10:00
Marathoon Fund Management , Managing Director at Firefinch Limited

© 2017 - Neuhu+